The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
From 2006 to 2014, alcohol‐related visits to the emergency department (ED) increased by 76% in the United States, highlighting the need for improved ED‐driven interventions addressing alcohol use disorder (AUD). Naltrexone is an FDA‐approved medication for AUD shown to decrease craving and self‐administration of alcohol. While oral naltrexone and extended‐release naltrexone have been long...